Business

ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive

articleAni Pharmaceuticals, Inc.May 27, 20213/company/ani-pharmaceuticals-inc/news/ani-pharmaceuticals-to-present-at-jefferies-virtual-healthcare-conference-2021-2021
ANI Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference 2021

About this update from Ani Pharmaceuticals, Inc.

[{"type":"text","content":" BAUDETTE, Minn.--(BUSINESS WIRE)--\nANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows:\n\n\nDate:\n\nFriday, June 4, 2021\n\n\n\n\n\nTime:\n\n\n\n10:00 a.m. ET\n\n\n\n\n\nWebcast Link:\n\n\n\nhttps://wsw.com/webcast/jeff174/anip/1843128\n\n\n\n\nThe presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.anipharmaceuticals.com, under the Investors section.\n\nAbout ANI\n\nANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. We focus on niche and high barrier to entry opportunities including controlled substances, oncology products (anti-cancer), hormones and steroids, and complex formulations. For more information, please visit our website www.anipharmaceuticals.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210527005702/en/\n\nInvestor Relations:\nLisa M. Wilson, In-Site Communications, Inc.\nT: 212-452-2793\nE: [email protected]\n\nSource: ANI Pharmaceuticals, Inc.","length":4010,"tagName":"div"}]

More updates from Ani Pharmaceuticals, Inc.